Hendrik Everaert

Phase I Study of ⁶⁸Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma

Marleen Keyaerts, Catarina Xavier, Johannes Heemskerk et al. · Journal of Nuclear Medicine · 2015 · 419 citations · Full text

Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu

Jacques De Grève, Erik Teugels, Caroline Geers et al. · Lung Cancer · 2012 · 277 citations · Full text

Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With Pembrolizumab

Jeroen de Filette, Yanina Jansen, Max Schreuer et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 242 citations · Full text

Prospective, Risk-Adapted Strategy of Stereotactic Body Radiotherapy for Early-Stage Non–Small-Cell Lung Cancer: Results of a Phase II Trial

Samuel Bral, Thierry Gevaert, Nadine Linthout et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 181 citations

Adaptive Radiotherapy, Radiation Medicine, Phase Ii Trial +9

The Impact of Accelerated HF-rTMS on the Subgenual Anterior Cingulate Cortex in Refractory Unipolar Major Depression: Insights From 18FDG PET Brain Imaging

Chris Baeken, Daniele Marinazzo, Hendrik Everaert et al. · Brain stimulation · 2015 · 138 citations · Full text

Neuroimaging Biomarkers, Psychiatry, Cortical Remodeling +12